Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Context Therapeutics Inc CNTX

Healthcare
Context Therapeutics Inc. is a biopharmaceutical company advancing medicines for solid tumors. The Company is building an advanced portfolio of clinical-stage T cell engaging bispecific therapeutics, including CTIM-76, a selective Claudin 6 (CLDN6) x CD3 bispecific antibody, and CT-95, a potential first-in-class mesothelin x CD3 bispecific antibody. CLDN6 is a tight junction membrane protein... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CNTX)

Context Therapeutics Reports Third Quarter 2024 Operating and Financial Results

GlobeNewswire November 6, 2024

Context Therapeutics to Participate in Upcoming Investor Conferences in November

GlobeNewswire October 23, 2024

Context Therapeutics Announces Poster Presentation at the Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting

GlobeNewswire October 16, 2024

BioAtla and Context Therapeutics Announce Exclusive Worldwide License Agreement to Develop and Commercialize BA3362, a Nectin-4 x CD3 T Cell Engaging Antibody

GlobeNewswire September 23, 2024

Context Therapeutics Appoints Dr. Karen Smith and Dr. Luke Walker to Board of Directors

GlobeNewswire September 4, 2024

Context Therapeutics Reports Second Quarter 2024 Operating and Financial Results

GlobeNewswire August 7, 2024

Context Therapeutics Appoints Chief Medical Officer and Vice President of Clinical Operations

GlobeNewswire August 1, 2024

Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95

GlobeNewswire July 10, 2024

Context Therapeutics Reports First Quarter 2024 Operating and Financial Results

GlobeNewswire May 8, 2024
View More News ››

Opinion & Analysis (NDAQ:CNTX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CNTX)

Context Therapeutics to Participate in Upcoming Investor Con

Breaking News: $CNTX Context Therapeutics to Participate in Upcoming Investor Conferences in NovemberPHILADELPHIA, Oct. 23, 2024 (GLOBE...
whytestocks - October 23, 2024

CNTX: Promising Bispecific Antibody Candidate Poised for Cli

http://beyondspx.com/2024/07/31/cntx-promising-bispecific-antibody-candidate-poised-for-clinical-advancement/
MikeTester - August 2, 2024

RE:CNTX...... mini pop to $1.15

SILO....... pop....now $3.65 Shoulda coulda
Iseneschal - February 2, 2023

CNTX...... mini pop to $1.15

I like to leave some for the next guy ; )  Cheers............oh....take a look at SILO on NASDAQ...share buyback! $2.75 u.s
Iseneschal - January 31, 2023

CNTX ....still climbing the RBL

$1.10 Me ...no position ; )
Iseneschal - January 31, 2023

CNTX.... vols are increasing and so is the

Share price  On watch
Iseneschal - January 31, 2023
View more Bullboard ››

Silvercorp Metals Inc.

Silvercorp Metals Inc.

Silvercorp is a Canadian mining company producing silver, gold, lead, and zinc with a long history of profitability and ...
View More »